Hypoglycaemia, analogue insulins; prescribing cost or quality of life?
Hitman, G A.
; 29(3): 289, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22364579
Trends in the use and cost of human and analogue insulins in a Colombian population, 2011-2015.
Cost-effectiveness of the psycho-educational blended (group and online) intervention HypoAware compared with usual care for people with Type 1 and insulin-treated Type 2 diabetes with problematic hypoglycaemia: analyses of a cluster-randomized controlled trial.
Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool.
The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.
Consensus on Bridges for Barriers to Insulin Therapy.
Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA<sub>1c</sub> , weight and hypoglycaemic event incidence.
Considerations for diabetes: treatment with insulin pen devices.
How many people inject insulin? UK estimates from 1991 to 2010.
The impact of insurance coverage and the family on pediatric diabetes management.
Overview of insulin delivery pen devices.